Christopher Thomas Giordano - CEO, Director at Tenax Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
TENX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Christopher Thomas Giordano - trading volume in the past year for Tenax Therapeutics, Inc.

Holdings reported by Christopher Thomas Giordano for Tenax Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 1.4M $10.1M $7.23 Nov 18, 2025 Direct Common Stock 1.4M
Common Stock 2.61K $19.8K $7.59 Nov 20, 2025 Direct

Transactions reported by Christopher Thomas Giordano for Tenax Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.